
About Cybrdi
Cybrdi is a publicly listed company based in Rockville (United States) founded in 2002. Tissue array products and banking services are provided by Cybrdi. Its chief executive, as recorded, is Yanbiao Bai. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is Cybrdi, Inc. Its competitors include BioLife Solutions, RoosterBio and OriGene; 2 of its 3 listed competitors have raised funding.
Company details
Cybrdi was established in 2002 in Rockville, United States, as a biotechnology firm focused on tissue array products. Various normal and diseased human tissues are collected through an integrated system, which supports the production of hundreds of tissue arrays. The product portfolio encompasses a broad selection of tissue arrays. Additional services include frozen tissue banking, FFPE banking, and tissue sectioning, all conducted within the biotechnology sector.
- Headquarters Rockville, United States
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website cybrdi.com
- Social LinkedIn
- Legal Name Cybrdi, Inc.
People of Cybrdi
1 people are tracked at Cybrdi (1 in leadership).
| Name | Role | Group |
|---|---|---|
Yanbiao Bai | CEO & President | Leadership |
Complete people profiles for Cybrdi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Cybrdi
Cybrdi has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and OriGene.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of Cybrdi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cybrdi
Websites that share an audience with Cybrdi (cybrdi.com).
Websites whose visitors overlap most with Cybrdi. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
tissue-cell-culture.com | tissue-cell-culture.com | 100% | β | ||
online.liebertpub.com | online.liebertpub.com | 77% | β | ||
| bioserve.com | 64% | View details | |||
| biochain.com | 62% | 20.6K | #1,374,754 | View details | |
flowgen.net | flowgen.net | 62% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 6 similar websites and full traffic analytics for Cybrdi
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Cybrdi (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cybrdi
Cybrdi was founded in 2002.
Cybrdi is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Yanbiao Bai is the CEO of Cybrdi, as recorded in our data.
Cybrdi was established in 2002 in Rockville, United States, as a biotechnology firm focused on tissue array products. Various normal and diseased human tissues are collected through an integrated system, which supports the production of hundreds of tissue arrays. The product portfolio encompasses a broad selection of tissue arrays. Additional services include frozen tissue banking, FFPE banking, and tissue sectioning, all conducted within the biotechnology sector.
Cybrdi's top competitors include RoosterBio, BioLife Solutions and OriGene.
Cybrdi operates through Cybrdi, Inc..